Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan-Reference-Cited by-同舟云学术

Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan

Published:2003-09 Issue:9 Volume:27 Page:783-788
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Shimamoto Takashi,Tohyama Kaoru,Okamoto Takahiro,Uchiyama Takashi,Mori Hiroyuki,Tomonaga Masao,Asano Yoshinobu,Niho Yoshiyuki,Teramura Masanao,Mizoguchi Hideaki,Omine Mitsuhiro,Ohyashiki Kazuma

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. Immunological abnormalities in myelodysplastic syndromes;Hamblin;Sem. Hematol.,1996

2. Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients;Okamoto;Int. J. Hematol.,1997

3. Immune abnormalities in myelodysplastic syndromes;Economopoulos;J. Clin. Pathol.,1985

4. Immunological abnormalities in myelodysplastic syndromes;Mufti;Br. J. Haematol.,1986

5. Immunonoregulatory abnormalities in myelodysplastic disorders;Baumann;Am. J. Hematol.,1986

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Outcomes, Survival, and Predictors in Lower-Risk Myelodysplastic Syndrome Patients Treated with Cyclosporine A;Acta Haematologica;2024-02-17

2. Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?;Cancers;2021-01-03

3. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-6 myelodysplastic syndromes (MDS);International Journal of Hematology;2020-02-14

4. Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant;Critical Reviews in Oncology/Hematology;2019-01

5. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity;Expert Review of Hematology;2017-06-15